Quality of Life and Device Acceptance in Patients With ICD Undergoing Remote ICD FU
Primary Purpose
Anxiety, Depression
Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
ICD remote monitoring
Control group
Sponsored by

About this trial
This is an interventional treatment trial for Anxiety focused on measuring Remote ICD follow-up, HRQoL, Health related Quality of Life, Depression, anxiety, device acceptance, telemedicine, telemonitoring
Eligibility Criteria
Inclusion Criteria:
- Patients willing to participate
- Patients with new-implantation of an ICD or device replacement due to battery depletion between May 2011 and April 2013
- Sufficient knowledge of the German language
- Expectancy of life >1 years at good clinical status
- Written informed consent
Exclusion Criteria:
- Age <18 years
- Subjects not able to give written informed consent
- Subjects without sufficient German language skills
Sites / Locations
- Bielefeld University, School of public health
- Munich University Clinic, Campus Grosshadern
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Other
Arm Label
ICD remote monitoring
Control group
Arm Description
Active Comparator: ICD remote monitoring additionally to regular in-office visits/FU 1,3,6 and 12 months post implantation of an ICD or post ICD replacement
Regular in-office visits/FU 1,3,6 and 12 months post implantation of an ICD or post ICD replacement w/o remote FU
Outcomes
Primary Outcome Measures
Influence of ICD remote monitoring on Quality of Life, measured by the EQ5D questionnaire
Secondary Outcome Measures
Influence of ICD remote monitoring on levels of anxiety and depression, measured by the HADS questionnaire (Hospital Anxiety and Depression scale)
Influence of ICD remote monitoring on device acceptance, measured by the Florida Patient acceptance scale (FPAS)
Full Information
NCT ID
NCT02888028
First Posted
July 3, 2014
Last Updated
June 20, 2018
Sponsor
LMU Klinikum
Collaborators
Klinikum Bielefeld
1. Study Identification
Unique Protocol Identification Number
NCT02888028
Brief Title
Quality of Life and Device Acceptance in Patients With ICD Undergoing Remote ICD FU
Official Title
Quality of Life and Device Acceptance in Patients With Implantable Cardioverter-defibrillators Undergoing Remote ICD Follow-up
Study Type
Interventional
2. Study Status
Record Verification Date
June 2018
Overall Recruitment Status
Completed
Study Start Date
May 2011 (undefined)
Primary Completion Date
April 2014 (Actual)
Study Completion Date
June 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
LMU Klinikum
Collaborators
Klinikum Bielefeld
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study investigates whether an additional remote follow-up of patients with implantable cardioverter-defibrillators (ICDs) has beneficial effects on Quality of life (QoL), levels of anxiety and depression and device acceptance. Patients are randomized to either conventional in-office FU only or additional remote surveillance, follow-up duration is 12 months. The influence of other variables (age, sex,..) is evaluated regarding their influence on study endpoints.
Detailed Description
The rising number of implantable cardiac devices leads to an increasing amount of device-related workload, e.g. regular in-office follow-ups (FU). New means of ICD FU strategies are necessary to handle the increasing burden. ICD remote monitoring promises a time- and cost efficient alternative to conventional in-office FU strategies. Many studies have already shown benefits on FU burden reduction, on saving of costs and time, and recently on total mortality. The impact of remote ICD FU on Quality of life, anxiety and depression levels and device acceptance is still under discussion. The aim of this trial is to investigate the influence of additional remote ICD surveillance on the primary endpoint health related quality of life (HRQoL), further on levels of anxiety and depression and on device acceptance.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Anxiety, Depression
Keywords
Remote ICD follow-up, HRQoL, Health related Quality of Life, Depression, anxiety, device acceptance, telemedicine, telemonitoring
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
182 (Actual)
8. Arms, Groups, and Interventions
Arm Title
ICD remote monitoring
Arm Type
Active Comparator
Arm Description
Active Comparator: ICD remote monitoring additionally to regular in-office visits/FU 1,3,6 and 12 months post implantation of an ICD or post ICD replacement
Arm Title
Control group
Arm Type
Other
Arm Description
Regular in-office visits/FU 1,3,6 and 12 months post implantation of an ICD or post ICD replacement w/o remote FU
Intervention Type
Procedure
Intervention Name(s)
ICD remote monitoring
Intervention Description
ICD remote monitoring additionally to regular in-office visits
Intervention Type
Other
Intervention Name(s)
Control group
Intervention Description
Regular in-office visits/FU 1,3,6 and 12 months post implantation of an ICD or post ICD replacement w/o remote FU
Primary Outcome Measure Information:
Title
Influence of ICD remote monitoring on Quality of Life, measured by the EQ5D questionnaire
Time Frame
12 months
Secondary Outcome Measure Information:
Title
Influence of ICD remote monitoring on levels of anxiety and depression, measured by the HADS questionnaire (Hospital Anxiety and Depression scale)
Time Frame
12 months
Title
Influence of ICD remote monitoring on device acceptance, measured by the Florida Patient acceptance scale (FPAS)
Time Frame
12 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients willing to participate
Patients with new-implantation of an ICD or device replacement due to battery depletion between May 2011 and April 2013
Sufficient knowledge of the German language
Expectancy of life >1 years at good clinical status
Written informed consent
Exclusion Criteria:
Age <18 years
Subjects not able to give written informed consent
Subjects without sufficient German language skills
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Johannes Siebermair, MD
Organizational Affiliation
Munich University Clinic, Campus Grosshadern, Munich, Germany
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Florian Leppert, MSc
Organizational Affiliation
Bielefeld University, School of public health Bielefeld, Germany
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Stefan Kääb, MD
Organizational Affiliation
Munich University Clinic, Campus Grosshadern, Munich, Germany
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Wolfgang Greiner, MD
Organizational Affiliation
Bielefeld University, School of public health, Bielefeld, Germany
Official's Role
Principal Investigator
Facility Information:
Facility Name
Bielefeld University, School of public health
City
Bielefeld
ZIP/Postal Code
33615
Country
Germany
Facility Name
Munich University Clinic, Campus Grosshadern
City
Munich
ZIP/Postal Code
81377
Country
Germany
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Quality of Life and Device Acceptance in Patients With ICD Undergoing Remote ICD FU
We'll reach out to this number within 24 hrs